27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Context

          The normal cortisol response 30 or 60 minutes after cosyntropin (ACTH [1–24]) is considered to be ≥18 μg/dL (500 nmol/L). This threshold is based on older serum cortisol assays. Specific monoclonal antibody immunoassays or LC-MS/MS may have lower thresholds for a normal response.

          Objective

          To calculate serum cortisol cutoff values for adrenocorticotropic hormone (ACTH) stimulation testing with newer specific cortisol assays.

          Methods

          Retrospective analysis of ACTH stimulation tests performed in ambulatory and hospitalized patients suspected of adrenal insufficiency (AI). Serum samples were assayed for cortisol in parallel using Elecsys I and Elecsys II immunoassays, and when volume was available, by Access immunoassay and LC-MS/MS.

          Results

          A total of 110 patients were evaluated. Using 18 μg/dL as the cortisol cutoff after ACTH stimulation, 14.5%, 29%, 22.4%, and 32% of patients had a biochemical diagnosis of AI using the Elecsys I, Elecsys II, Access, and LC-MS/MS assays, respectively. Deming regressions of serum cortisol were used to calculate new cortisol cutoffs based on the Elecsys I cutoff of 18 μg/dL. For 30-minute values, new cutoffs were 14.6 μg/dL for Elecsys II, 14.8 μg/dL for Access, and 14.5 μg/dL for LC-MS/MS. Baseline cortisol <2 μg/dL was predictive of subnormal stimulated cortisol values.

          Conclusion

          To reduce false positive ACTH stimulation testing, we recommend a new serum cortisol cutoff of 14 to 15 μg/dL depending on the assay used (instead of the historical value of 18 μg/dL with older polyclonal antibody assays). Clinicians should be aware of the new cutoffs for the assays available to them when evaluating patients for AI.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

          This clinical practice guideline addresses the diagnosis and treatment of primary adrenal insufficiency.
            • Record: found
            • Abstract: found
            • Article: not found

            Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.

            To develop consensus statements for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients. A multidisciplinary, multispecialty task force of experts in critical care medicine was convened from the membership of the Society of Critical Care Medicine and the European Society of Intensive Care Medicine. In addition, international experts in endocrinology were invited to participate. The task force members reviewed published literature and provided expert opinion from which the consensus was derived. The consensus statements were developed using a modified Delphi methodology. The strength of each recommendation was quantified using the Modified GRADE system, which classifies recommendations as strong (grade 1) or weak (grade 2) and the quality of evidence as high (grade A), moderate (grade B), or low (grade C) based on factors that include the study design, the consistency of the results, and the directness of the evidence. The task force coined the term critical illness-related corticosteroid insufficiency to describe the dysfunction of the hypothalamic-pituitary-adrenal axis that occurs during critical illness. Critical illness-related corticosteroid insufficiency is caused by adrenal insufficiency together with tissue corticosteroid resistance and is characterized by an exaggerated and protracted proinflammatory response. Critical illness-related corticosteroid insufficiency should be suspected in hypotensive patients who have responded poorly to fluids and vasopressor agents, particularly in the setting of sepsis. At this time, the diagnosis of tissue corticosteroid resistance remains problematic. Adrenal insufficiency in critically ill patients is best made by a delta total serum cortisol of or = 7 days is recommended for septic shock. Methylprednisolone in a dose of 1 mg x kg(-1) x day(-1) for > or = 14 days is recommended in patients with severe early acute respiratory distress syndrome. Glucocorticoids should be weaned and not stopped abruptly. Reinstitution of treatment should be considered with recurrence of signs of sepsis, hypotension, or worsening oxygenation. Dexamethasone is not recommended to treat critical illness-related corticosteroid insufficiency. The role of glucocorticoids in the management of patients with community-acquired pneumonia, liver failure, pancreatitis, those undergoing cardiac surgery, and other groups of critically ill patients requires further investigation. Evidence-linked consensus statements with regard to the diagnosis and management of corticosteroid deficiency in critically ill patients have been developed by a multidisciplinary, multispecialty task force.
              • Record: found
              • Abstract: not found
              • Article: not found

              Adrenal insufficiency.

              W Oelkers (1996)

                Author and article information

                Contributors
                Journal
                J Endocr Soc
                J Endocr Soc
                jes
                Journal of the Endocrine Society
                Oxford University Press (US )
                2472-1972
                01 April 2021
                18 February 2021
                18 February 2021
                : 5
                : 4
                : bvab022
                Affiliations
                [1 ] Endocrinology Center and Clinics, Froedtert & the Medical College of Wisconsin , Milwaukee, WI 53051, USA
                [2 ] Division of Endocrinology and Molecular Medicine, Department of Medicine, Medical College of Wisconsin , Milwaukee, WI 53226, USA
                [5 ] Endocrine Research Laboratory, Aurora St. Luke’s Medical Center, Advocate Aurora Research Institute , Milwaukee, WI 53215, USA
                [3 ] Department of Laboratory Medicine and Pathology , Mayo Clinic, Rochester, MN 55905, USA
                [4 ] Department of Pathology, Medical College of Wisconsin , Milwaukee, WI 53226, USA
                Author notes
                Correspondence: Bradley R Javorsky, MD, Endocrinology Center and Clinics, Froedtert & the Medical College of Wisconsin, W129 N7055 Northfield Drive, Building A, Suite 203, Menomonee Falls, WI 53051, USA. E-mail: bradley.javorsky@ 123456froedtert.com .
                Author information
                https://orcid.org/0000-0001-5052-3043
                https://orcid.org/0000-0002-5128-8476
                https://orcid.org/0000-0002-1310-6563
                Article
                bvab022
                10.1210/jendso/bvab022
                7975762
                33768189
                f74540e5-c99c-4d11-83d2-99501604af70
                © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence ( http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 01 February 2021
                : 10 February 2021
                : 19 March 2021
                Page count
                Pages: 11
                Funding
                Funded by: Advocate Aurora Research Institute;
                Categories
                Clinical Research Articles
                AcademicSubjects/MED00250

                acth stimulation testing,cosyntropin,monoclonal cortisol immunoassay,lc-ms/ms

                Comments

                Comment on this article

                Related Documents Log